Literature DB >> 8509943

Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.

S Sawada1, H Hashimoto, S Iijima, Y Tokano, M Takei, M Shida, T Obara.   

Abstract

This study attempted to estimate soluble CD4(sCD4)/CD8(sCD8) molecules in active systemic lupus erythematosus (SLE) patients. Measurements were made by solid-phase enzyme-linked immunosorbent assay. sCD8 or sCD4 molecules were significantly increased in the patients as compared to control subjects. sCD8 correlated with the erythrocyte sedimentation rate. sCD4 correlated with the anti DNA antibody titer, the IgG concentration, and negatively with the complement titer. An association of these molecules with immunologic abnormalities and disease activity exists in SLE patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509943     DOI: 10.1002/jcla.1860070303

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  6 in total

1.  Lower concentration of serum soluble CD8 in severe Hashimoto's disease.

Authors:  N Yamamoto; M Watanabe; F Matsuzuka; A Miyauchi; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

2.  Soluble Fas molecule in the serum of patients with systemic lupus erythematosus.

Authors:  Y Tokano; S Miyake; N Kayagaki; K Nozawa; S Morimoto; M Azuma; H Yagita; Y Takasaki; K Okumura; H Hashimoto
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

3.  Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.

Authors:  S Sawada; H Hashimoto; S Iijma; Y Tokano; Y Matsukawa; M Takei; H Ishikawa; H Kang; K Tomura; K Mitamura
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

4.  Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.

Authors:  T Kitoh; H Ishikawa; S Sawada; K Koshino; Y Tokano; H Hashimoto; S Nakagawa
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.

Authors:  Y Tokano; T Obara; H Hashimoto; K Okumura; S Hirose
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

6.  Increased soluble CD4 in serum of rheumatoid arthritis patients is generated by matrix metalloproteinase (MMP)-like proteinases.

Authors:  Wen-Yi Tseng; Yi-Shu Huang; Nien-Yi Chiang; Yeh-Pin Chou; Yeong-Jian Jan Wu; Shue-Fen Luo; Chang-Fu Kuo; Ko-Ming Lin; Hsi-Hsien Lin
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.